Immune Checkpoint Inhibitor-Associated Myositis: Expanding the Spectrum of Cardiac Complications of the Immunotherapy Revolution.

Anquetil C, Salem JE, Lebrun-Vignes B, Johnson DB, Mammen AL, Stenzel W, LĂ©onard-Louis S, Benveniste O, Moslehi JJ, Allenbach Y
Circulation. 2018 138 (7): 743-745

PMID: 30359135 · DOI:10.1161/CIRCULATIONAHA.118.035898

MeSH Terms (17)

Adult Adverse Drug Reaction Reporting Systems Aged Aged, 80 and over Antineoplastic Agents, Immunological Databases, Factual Female Humans Immunotherapy Male Middle Aged Myositis Pharmacovigilance Prognosis Risk Assessment Risk Factors Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: